Suppression of interleukin-1β-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase

Biochemistry

Volumn 41, Issue 50, 2002, Pages 14726-14733

  Guo, Li ^a   Zhang, Zhiquan ^a   Green, Katherine ^a   Stanton, Robert C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL LINES;

BIOSYNTHESIS; CELLS; ENZYMES; GLUCOSE; INSULIN; PHOSPHATES; RNA;

BIOCHEMISTRY;

CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; MALATE DEHYDROGENASE (DECARBOXYLATING); N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME ACTIVITY; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEHYDROEPIANDROSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; GLUCOSEPHOSPHATE DEHYDROGENASE; INTERLEUKIN-1; MALATE DEHYDROGENASE; MALE; NADP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDES, ANTISENSE; OMEGA-N-METHYLARGININE; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037126681     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi026110v     Document Type: Article

References (48)

1. Bach, J. F. (1995) J. Autoimmun. 8, 439-463.
2. Eizirik, D. L., Sandler, S., and Palmer, J. P. (1993) Diabetes 42, 1389-1391.
3. Mandrup-Poulsen, T., Helquist, S., Wogensen, L., et al. (1990) Curr. Top. Microbiol. Immunol. 164, 169-193.
4. Rabinovitch, A. (1993) Diabetes Rev. 1, 215-240.
5. Andre-Schmutz, I., Hindelang, C., Benoist, C., and Mathis, D. (1999) Eur. J. Immunol. 29, 245-255.
6. Ankarcrona, M., Dypbukt, J. M., Brune, B., and Nicotera, P. (1994) Exp. Cell Res. 213, 172-177.
7. Corbett, J. A., Wang, J. L., Sweetland, M. A., Lancaster, J. R., Jr., and McDaniel, M. L. (1992) J. Clin. Invest. 90, 2384-2391.
8. Costa, R. L.-F.B.P., Curi, R., Murphy, C., and Newsholme, P. (1995) Biochem. J. 310, 709-714.
9. Messmer, U. K., and Brune, B. (1994) Cell Signalling 6, 17-24.
10. Corbett, J. A., and McDaniel, M. L. (1995) J. Exp. Med. 181, 559-568.
11. Sandler, S., Eizirik, D. L., Svensson, C., Strandell, E., Welsh, M., and Welsh, N. (1991) Autoimmunity 10, 241-253.
12. Corbett, J. A., Sweetland, M. A., Wang, J. L., et al. (1993) Proc. Natl. Acad. Sci. U.S.A. 90, 1731-1735.
13. Eizirik, D. L., Sandler, S., Welsh, N., et al. (1994) J. Clin. Invest. 93, 1968-1974.
14. Eizirik, D. L., Sandler, S., Welsh, N., et al. (1994) Autoimmunity 19, 193-198.
15. Rabinovitch, A., Suarez-Pinzon, W. L., Strynadka, K., et al. (1994) J. Clin. Endocrinol. Metab. 79, 1058-1062.
16. Eizirik, D. L., Cagliero, E., Björklund, A., and Welsh, N. (1992) FEBS Lett. 308, 249-252.
17. Southern, C., Schulster, D., and Green, I. C. (1990) FEBS Lett. 276, 42-44.
18. Welsh, N., Eizirik, D. L., Bendtzen, K., et al. (1991) Endocrinology 129, 3167-3173.
19. Corbett, J. A., Lancaster, J. R., Jr., Sweetland, M. A., et al. (1991) J. Biol. Chem. 266, 21351-21354.
20. Welsh, N., Eizirik, D. L., Bendtzen, K., and Sandler, S. (1991) Endocrinology 129, 3167-3173.
21. Eizirik, D. L., Welsh, N., Niemann, A., et al. (1994) FEBS Lett. 337, 298-302.
22. De-Mello, M. A., Flodstrom, M., and Eizirik, D. L. (1996) Biochem. Pharmacol. 52, 1703-1709.
23. Delaney, C. A., Green, M. H. L., Lowe, J. E., and Green. I. C. (1993) FEBS Lett. 333, 291-295.
24. Fehsel, K., Jalowy, A., Qi, S., et al. (1993) Diabetes 42, 496-500.
25. Nathan, C., and Xie, Q. W. (1994) Cell 78, 915-918.
26. Laffranchi, R., Schoedon, G., Blau, N., and Spinas, G. A. (1997) Biochem. Biophys. Res. Commun. 233, 66-70.
27. Leopold, J., Cap, A., Scribner, A, W., et al. (2001) FASEB J. 15, 1771-1773.
28. Tian, W., Braunstein, L. D., Pang, J., and Stanton, R. C. (1998) J. Biol. Chem. 273, 10609-10617.
29. MacDonald, M. J. (1995) J. Biol. Chem. 270, 20051-20058.
30. Jesaitis, A. J., and Allen, R. A. (1988) J. Bioenerg. Biomembr. 20, 679-707.
31. Tian, W. N., Pignatare, J. N., and Stanton, R. C. (1994) J. Biol. Chem. 269, 14798-14805.
32. Corraliza, J. M., Campo, M. L., Fuentes, J. M., et al. (1993) Biochem. Biophys. Res. Commun. 196, 342-347.
33. McDaniel, M. L., Colca, J. R., Kotagal, N., and Lacy P. E. (1983) Methods Enzymol. 98, 182-200.
34. Zhang, Z., Yu, J., and Stanton, R. C. (2000) Anal. Biochem. 285, 163-167.
35. Wise, E. M., Jr., and Ball, E. G. (1964) Biochemistry 52, 1255-1262.
36. Ding, A. H., Nathan, C. F., and Stuehr, D. J. (1988) J. Immunol. 141, 2407-2412.
37. Springer, T. A. (1991) Current Protocols in Molecular Biology, Vol. 2, Green Publishing Associates and Wiley-Interscience, New York.
38. Laemmli, U. K. (1970) Nature 227, 680-685.
39. Kwon, G., Corbett, S. H., Hill, J. R., et al. (1998) Diabetes 47, 583-591.
40. Messmer, U. K., and Brune, B. (1994) Cell Signalling 6, 17-24.
41. Ishibashi, T., Godecke, A., and Schrader, J. (2001) Tohoku J. Exp. Med. 194, 75-90.
42. Zhang, Z., Apse, K., Pang, J., and Stanton, R. C. (2000) J. Biol. Chem. 275, 40042-40047.
43. Sandler, S., Bendtzen, K., Eizirik, D. L., et al. (1990) Immunol. Lett. 26,245-252.
44. Sjohlom, A. (1991) FEBS Lett. 289, 249-252.
45. Salvemini, F., Franzé, A., Iervolino, A., et al. (1999) J. Biol. Chem. 274, 2750-2757.
46. Laychock, S. G., and Bauer, A. L. (1996) Endocriology 137, 3375-3385.
47. Laychock, S. G. (1998) Biochem. Pharmacol. 55, 1453-1464.
48. Eizirik, D. L., Flodstrom, M., Karlsen, A. E., and Welsh, N. (1996) Diabetologia 39, 875-890.